Literature DB >> 32540326

Letter to the Editor: CoVid-19 and type 1 diabetes: Every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in type 1 diabetes.

P Tatti1, G Tonolo2, A Zanfardino3, D Iafusco3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32540326      PMCID: PMC7834151          DOI: 10.1016/j.diabres.2020.108270

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


× No keyword cloud information.
We read with great interest the paper from Pitocco et al. [1], that raises the point of the remarkable absence of clinical CoV infection in the type 1 diabetic population. The Authors suggest a search of such cases in subjects with type 1 diabetes, who represent a high risk population. We recently published a paper on this topic in in the Journal of Medical Hypotheses [2]. One of the CoAuthors, who is in charge of a large Diabetes Centre in Sardinia, has made a search in this area, one of the three with the highest incidence of Type 1 diabetes in the world, and has not found cases of clinical CoVid-19 infection. The same is true in other areas of Italy, Lazio and Campania where the other Authors work. We have not found cases also within the adult type 1 population, which makes unlikely the idea that “the young age” may have a role in the immunity of these subjects. Furthermore all type 1 diabetic subjects share a common genetic background. The suggestion of the Authors [1] that the early application of the common protective measures to Type 1 population may have safeguarded them, is equally unlikely because, as recently proven, the virus was present well before the closure of the flights from China [3], at least on Dec 1, 2019. This lack of alternative explanations is consistent with our hypothesis, that the absence of clinical manifestations of CoV infection is, at least in part, due to some genetically determined characteristics of their TH1 immunity. The TH1 immunity is one of the determinants of the Beta cell destruction but, in virtue of its effectiveness against virus, may be among the protective body machinery against the CoV-19 virus.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  3 in total

1.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

2.  Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?

Authors:  Dario Pitocco; Linda Tartaglione; Luca Viti; Mauro Di Leo; Andrea Manto; Salvatore Caputo; Alfredo Pontecorvi
Journal:  Diabetes Res Clin Pract       Date:  2020-05-19       Impact factor: 5.602

3.  Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19?

Authors:  Patrizio Tatti; Giancarlo Tonolo; Angela Zanfardino; Dario Iafusco
Journal:  Med Hypotheses       Date:  2020-04-29       Impact factor: 1.538

  3 in total
  5 in total

1.  Diabetes and mortality in patients with COVID-19: Are we missing the link?

Authors:  Alessandro Sticchi; Alberto Cereda; Marco Toselli; Antonio Esposito; Anna Palmisano; Davide Vignale; Valeria Nicoletti; Riccardo Leone; Chiara Gnasso; Alberto Monello; Arif A Khokhar; Alessandra Laricchia; Andrea Biagi; Piergiorgio Turchio; Marcello Petrini; Guglielmo Gallone; Francesco De Cobelli; Francesco Ponticelli; Gianni Casella; Gianmarco Iannopollo; Tommaso Nannini; Carlo Tacchetti; Antonio Colombo; Francesco Giannini
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

2.  A Diabetes and COVID-19 Dilemma: Balancing Parents' Health & Children's Education.

Authors:  Paras B Mehta; Robert J Rushakoff
Journal:  J Diabetes Sci Technol       Date:  2020-08-14

Review 3.  Issues for the management of people with diabetes and COVID-19 in ICU.

Authors:  Antonio Ceriello; Eberhard Standl; Doina Catrinoiu; Baruch Itzhak; Nebojsa M Lalic; Dario Rahelic; Oliver Schnell; Jan Škrha; Paul Valensi
Journal:  Cardiovasc Diabetol       Date:  2020-07-20       Impact factor: 9.951

4.  "CoVidentary": An online exercise training program to reduce sedentary behaviours in children with type 1 diabetes during the COVID-19 pandemic.

Authors:  Valeria Calcaterra; Dario Iafusco; Vittoria Carnevale Pellino; Chiara Mameli; Gianluca Tornese; Antonietta Chianese; Crescenzo Cascella; Maddalena Macedoni; Francesca Redaelli; Gianvincenzo Zuccotti; Matteo Vandoni
Journal:  J Clin Transl Endocrinol       Date:  2021-07-10

Review 5.  COVID-19 and Type 1 Diabetes: Concerns and Challenges.

Authors:  Lorenzo Iughetti; Viola Trevisani; Umberto Cattini; Patrizia Bruzzi; Laura Lucaccioni; Simona Madeo; Barbara Predieri
Journal:  Acta Biomed       Date:  2020-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.